Sunny Pharmtech Inc. (TPEX: 6676)

Market Cap	3.30B
Revenue (ttm)	485.01M
Net Income (ttm)	-50.48M
Shares Out	148.76M
EPS (ttm)	-0.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,439
Open	22.70
Previous Close	22.20
Day's Range	21.80 - 22.70
52-Week Range	21.80 - 38.15
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Sunny Pharmtech

Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infect...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 138
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6676

Financial Performance

In 2023, Sunny Pharmtech's revenue was 428.83 million, an increase of 19.26% compared to the previous year's 359.59 million. Losses were -63.32 million, -62.81% less than in 2022.